Status:
COMPLETED
Effect of Red Beetroot Juice Intake in Adults With Long COVID-19
Lead Sponsor:
Catholic University of the Sacred Heart
Conditions:
Long COVID
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
Red beetroot juice may have positive effects on multiple pathways involved in long COVID. The aim of this pilot study was to explore the impact of beetroot juice supplementation on physical function, ...
Detailed Description
A single-center, double-blind, placebo-controlled randomized trial to test the effects of 14 days of beetroot juice supplementation on functional and biological outcomes in adults with long-COVID. Pa...
Eligibility Criteria
Inclusion
- a certification of a previous SARS-CoV-2 infection
- a negative COVID-19 swab test at least four weeks prior to the screening visit
- meet the criteria for long-COVID diagnosis according to the World Health Organization criteria
- report persistent fatigue
Exclusion
- intolerance to beetroot juice or its derivatives
- clinical conditions and/or use of medications that may interfere with trial outcomes (e.g., pregnancy or breastfeeding, diabetes, use of steroids or non-steroidal anti-inflammatory drugs, immunosuppressants, nitrates)
- participation in other intervention trials for long-COVID
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT06535165
Start Date
March 1 2021
End Date
July 31 2021
Last Update
August 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Aging and Geriatrics Research - UCSC
Rome, Italy, 00168